… concerns about the immunosuppressive approach being … (HSCT), either autologous or
allogeneic HSCT, may be a … insulin use, but at a lower dose than that used before transplantation. …

… (allogeneic) or from the patient itself (autologous) to restore the bone marrow function eradicated
by high doses of … They are mainly related to CNS toxicity of immunosuppressive drugs …

… tion of glucocorticoid with calcium channel blockers in large dose, … injection of autologous
and allogeneic placentally derived … fully allogenic islet grafts by the immunosuppressive activity …

… of potent new immunosuppressant has led to a lower rate of … dose was declined to 1/3 of
original dose, but glucocorticoid … Early onset Pneumocystis carinii pneumonia after allogeneic …

… great therapeutic potential in both autologous and allogeneic settings. Although autologous
transplantation is a safe … These unique immunosuppressive properties render them safe for …

… in this era of immunosuppression was performed in September … , cultured and used in
autologous transplantation. They have the … Furthermore, daily administration of low dose FK506 …

… The potential use of allogeneic islet transplantation in curing … need for sustained and heavy
immunosuppressive therapy. … immunosuppression and associated adverse or toxic effects. …

… the reliability of the autologous transplant approach. However… side effects from the procedure
or the immunosuppressant … intravenous injections of high and low doses of dental pulp-…

… wound healing in allogeneic skin grafts from miniature pigs. An allogeneic skin graft model
… postoperative interventions on allogeneic skin graft skin pieces: allogeneic skin graft group (…

… A recent/ ongoing phase-II clinical trial (Identifier number NCT03384433) aimed to
investigate the therapeutic effects of allogenic MSC-Exos in patients with acute IS. Intranasal …